申请人:Kawanishi Yasuyuki
公开号:US20070015762A1
公开(公告)日:2007-01-18
The present invention provides a pharmaceutical composition for use as an NPY Y5 receptor antagonist comprising a compound of the formula (I):
wherein R
1
is lower alkyl, cycloalkyl or the like,
R
2
is hydrogen, lower alkyl or the like,
n is 1 or 2, X is lower alkylene, lower alkenylene, arylene, cycloalkylene or the like,
Y is CONR
7
, CSNR
7
, NR
7
CO, NR
7
CS or the like,
Z is lower alkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl or the like and R
7
is hydrogen or lower alkyl,
prodrug, pharmaceutically acceptable salt or solvate thereof
本发明提供了一种用作NPY Y5受体拮抗剂的药物组合物,包括公式(I)中的化合物:
其中R1是较低的烷基、环烷基或类似物,R2是氢、较低的烷基或类似物,n为1或2,X为较低的烷基、较低的烯基、芳基、环烷基或类似物,Y为CONR7、CSNR7、NR7CO、NR7CS或类似物,Z为较低的烷基、可选择的取代的碳环烷基、可选择的取代的杂环烷基或类似物,R7为氢或较低的烷基,前药、药学上可接受的盐或溶剂。